Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Hildesheim

Showing results (61-70 of 360) with videos related to

Pageof 36
Sort By:
The Journal of Infectious Diseases|December 8, 2011
Longitudinal analysis of carcinogenic human papillomavirus infection and associated cytologic abnormalities in the Guanacaste natural history study: looking ahead to cotestingSarah Coseo Markt, Ana C Rodriguez, Robert D Burk, et al.
American Journal of Epidemiology|July 12, 2013
Impact of human papillomavirus vaccination on cervical cytology screening, colposcopy, and treatmentAna Cecilia Rodríguez, Diane Solomon, Rolando Herrero, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 17, 2007
Evaluation of the association with cervical cancer of polymorphisms in syndecan-1, a heparan sulfate proteoglycan involved with viral cell entryKelly J Yu, Arman Bashirova, Margaret M Madeleine, et al.
Frontiers in Oncology|June 28, 2012
Oral Immunoglobulin Levels are Not a Good Surrogate for Cervical Immunoglobulin LevelsTroy J Kemp, Mahboobeh Safaeian, Samantha Miner, et al.
Clinical and Vaccine Immunology : CVI|November 23, 2007
Evaluation of two types of sponges used to collect cervical secretions and assessment of antibody extraction protocols for recovery of neutralizing anti-human papillomavirus type 16 antibodiesTroy J Kemp, Allan Hildesheim, Roni T Falk, et al.
BMC Infectious Diseases|October 2, 2022
Estimating vaccine effectiveness against SARS-CoV-2 infection, hospitalization and death from ecologic data in Costa RicaRomain Fantin, Rolando Herrero, Allan Hildesheim, et al.
International Journal of Cancer|October 16, 2023
Association of aflatoxin with gallbladder cancer in a case-control study nested within a Chinese cohortJill Koshiol, Bin Zhu, Renwei Wang, et al.
International Journal of Cancer|March 10, 2011
Contribution of TMC6 and TMC8 (EVER1 and EVER2) variants to cervical cancer susceptibilityFelipe A Castro, Emma L Ivansson, Markus Schmitt, et al.
The Journal of Infectious Diseases|February 24, 2011
Long-term persistence of prevalently detected human papillomavirus infections in the absence of detectable cervical precancer and cancerPhilip E Castle, Ana Cecilia Rodríguez, Robert D Burk, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 2, 2024
Optimization and Local Cost-Effectiveness of Nasopharyngeal Carcinoma Screening Strategies in Southern China: Secondary Analysis of the Guangdong Randomized TrialJacob A Miller, Zhiwei Liu, Benjamin A Pinsky, et al.
Pageof 36

Showing results (61-70 of 360) with videos related to

Sort By:
Pageof 36
The Journal of Infectious Diseases|December 8, 2011
Longitudinal analysis of carcinogenic human papillomavirus infection and associated cytologic abnormalities in the Guanacaste natural history study: looking ahead to cotestingSarah Coseo Markt, Ana C Rodriguez, Robert D Burk, et al.
American Journal of Epidemiology|July 12, 2013
Impact of human papillomavirus vaccination on cervical cytology screening, colposcopy, and treatmentAna Cecilia Rodríguez, Diane Solomon, Rolando Herrero, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 17, 2007
Evaluation of the association with cervical cancer of polymorphisms in syndecan-1, a heparan sulfate proteoglycan involved with viral cell entryKelly J Yu, Arman Bashirova, Margaret M Madeleine, et al.
Frontiers in Oncology|June 28, 2012
Oral Immunoglobulin Levels are Not a Good Surrogate for Cervical Immunoglobulin LevelsTroy J Kemp, Mahboobeh Safaeian, Samantha Miner, et al.
Clinical and Vaccine Immunology : CVI|November 23, 2007
Evaluation of two types of sponges used to collect cervical secretions and assessment of antibody extraction protocols for recovery of neutralizing anti-human papillomavirus type 16 antibodiesTroy J Kemp, Allan Hildesheim, Roni T Falk, et al.
BMC Infectious Diseases|October 2, 2022
Estimating vaccine effectiveness against SARS-CoV-2 infection, hospitalization and death from ecologic data in Costa RicaRomain Fantin, Rolando Herrero, Allan Hildesheim, et al.
International Journal of Cancer|October 16, 2023
Association of aflatoxin with gallbladder cancer in a case-control study nested within a Chinese cohortJill Koshiol, Bin Zhu, Renwei Wang, et al.
International Journal of Cancer|March 10, 2011
Contribution of TMC6 and TMC8 (EVER1 and EVER2) variants to cervical cancer susceptibilityFelipe A Castro, Emma L Ivansson, Markus Schmitt, et al.
The Journal of Infectious Diseases|February 24, 2011
Long-term persistence of prevalently detected human papillomavirus infections in the absence of detectable cervical precancer and cancerPhilip E Castle, Ana Cecilia Rodríguez, Robert D Burk, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 2, 2024
Optimization and Local Cost-Effectiveness of Nasopharyngeal Carcinoma Screening Strategies in Southern China: Secondary Analysis of the Guangdong Randomized TrialJacob A Miller, Zhiwei Liu, Benjamin A Pinsky, et al.
Pageof 36